Related references
Note: Only part of the references are listed.Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Genomics Education for Health Care Professionals in the 21st Century
W. Gregory Feero et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
Vicki Leigh Keedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration
Issam Zineh et al.
PHARMACOTHERAPY (2011)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support
Casey Lynnette Overby et al.
BMC BIOINFORMATICS (2010)
Enrichment of Clinical Study Populations
R. Temple
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection
P. J. Clark et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Acceptance of Biomarker-Based Tests for Application in Clinical Practice: Criteria and Obstacles
M. Pirmohamed
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
Robert Pirker et al.
Journal of Thoracic Oncology (2010)
The Path to Personalized Medicine
Margaret A. Hamburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systematic review of pharmacoeconomic studies of pharmacogenomic tests
Mathieu Beaulieu et al.
PHARMACOGENOMICS (2010)
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
Steven M. Teutsch et al.
GENETICS IN MEDICINE (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: Are primary care physicians ready?
A. E. Shields et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacogenetics: From bench to byte
J. J. Swen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Abacavir hypersensitivity: a model system for pharmacogenetic test adoption
Myla Lai-Goldman et al.
GENETICS IN MEDICINE (2008)
From best evidence to best practice: effective implementation of change in patients' care
R Grol et al.
LANCET (2003)
Share Paper
